You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 19, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Masato Yoneda1, Yoshio Sumida2, Yoshihiro Kamada3
1Department of Gastroenterology and Hepatology, Yokohama City University, Yokohama, Japan.
Altmetric scores correlate with expert assessments of research impact in metabolic dysfunction-associated steatotic liver disease (MASLD). This suggests altmetrics can help physicians quickly find innovative noninvasive tests (NITs) for MASLD.
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: